Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors
Completed · Phase 1
Conditions studied: Brain and Central Nervous System Tumors, Metastatic Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Collecting fluid samples through a catheter may help doctors find out how well temozolomide spreads throughout the brain. PURPOSE: This clinical trial is studying temozolomide in treating patients with primary brain tumors or metastatic brain tumors.
Key facts
- Study ID
- NCT00547131
- Run by
- City of Hope Medical Center
- People needed
- 12
- Starts
- 2006-01-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2018-04-17
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope Comprehensive Cancer Center — Duarte, California, United States
- City of Hope Medical Group — Pasadena, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.